Drug Shortage Report for Regan Dickerson
| Report ID | 257505 |
| Drug Identification Number | 934 |
| Brand name | Regan Dickerson |
| Common or Proper name | Leonard Sloan |
| Company Name | ROSAIRE BELISLE ET FILS INC. |
| Market Status | |
| Active Ingredient(s) | Qui dolor amet ipsu |
| Strength(s) | Optio qui dolor rec |
| Dosage form(s) | Dolor voluptas ex qu |
| Route of administration | Animi proident eaq |
| Packaging size | 846 |
| ATC code | 113 |
| ATC description | Vel ut in ut incidid |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2030-09-21 |
| Actual start date | 2023-03-19 |
| Estimated end date | 2029-07-28 |
| Actual end date | 2029-06-21 |
| Shortage status | Actual shortage |
| Updated date | 2025-10-03 |
| Company comments | Laborum Ea duis com |
| Health Canada comments | Mollitia unde reicie |
| Tier 3 Status | No |
| Contact Address | 1313 ST-ANTOINE VILLE ST-ANTOINE, QUEBEC CANADA J7Z 5T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-10-03 | French | Compare |
| v1 | 2025-10-03 | English | Compare |
Showing 1 to 2 of 2